🦠 Probiotic Survival Gastric Acid Barrier Simulator

Swallowing the Probiotic Dose

A capsule of live organisms begins its journey to the gut.

• 1–10 B: Typical dose (CFU per capsule)
• ~10 s: Mouth-to-stomach transit (via esophagus)
• Lacto/Bifido: Common genera (most used strains)
• $70B+: Global market size (probiotic industry)

What is a probiotic dose

Live microorganisms packaged for a therapeutic health benefit.

Billions of live cells must survive to matter clinically.

Capsule composition

Freeze-dried organisms suspended in a protective carrier matrix.

The journey ahead

Next stop: the stomach, the harshest barrier in the gut.

Entering the Gastric Environment

Stomach acid creates one of the body's harshest microbial barriers.

• 1.5–3.5: Stomach pH range (fasting conditions)
• 1–4 h: Gastric emptying time (liquid to solid meals)
• ~2.0: Pepsin optimum pH (protein digestion enzyme)
• ~1.5 L: Daily HCl secreted (gastric parietal cells)

Why the stomach is hostile

Hydrochloric acid denatures proteins and kills most bacteria.

Few ingested microbes survive gastric transit unprotected.

pH as a barrier

Lower pH means faster, more lethal organism inactivation.

Residence time matters

Longer stomach dwell time increases cumulative acid exposure.

Strain-Dependent Population Loss

Some strains tolerate acid far better than others.

• <10%: Low-resistance survival (uncoated, sensitive strain)
• ~60%: High-resistance survival (uncoated, hardy strain)
• Moderate: Lactobacillus tolerance (generally acid-tolerant)
• Low: Bifidobacterium tolerance (generally acid-sensitive)

Strain-to-strain variation

Acid resistance differs widely across probiotic species.

Strain selection alone can shift survival many-fold.

Mechanisms of tolerance

Proton pumps and stress proteins buffer internal pH.

Consequence for dosing

Sensitive strains need much higher starting doses.

Enteric Coating Shields the Payload

A pH-sensitive shell keeps acid away from the organisms.

• >90%: Coated survival rate (across resistance levels)
• pH 6–7: Coating dissolves at (intestinal environment)
• Methacrylate: Common material (polymer copolymer)
• Improved: Shelf stability (vs uncoated capsules)

How enteric coating works

The shell resists acid but dissolves in alkaline intestine.

Coating decouples survival from strain acid resistance.

Formulation trade-offs

Coating adds cost and manufacturing complexity.

When coating is skipped

Uncoated formulas rely entirely on strain hardiness.

Arrival at the Small Intestine

Surviving organisms reach their intended site of action.

• Small intestine: Target zone (duodenum to ileum)
• ~6–7: Duodenal pH (near neutral)
• Hours: Colonization window (transient residence)
• ~10⁹ CFU: Effective dose needed (for measurable benefit)

Why delivery matters

Only surviving organisms can exert any health benefit.

Formulation and strain choice together decide final dose.

Beyond the stomach

Bile and pancreatic enzymes pose further downstream challenges.

Measuring success

Viable delivered count predicts likely clinical effect.